Senti Biosciences (SNTI) Cash from Investing Activities (2021 - 2025)

Senti Biosciences has reported Cash from Investing Activities for 5 years, with the latest figure at -$184000.0 in Q2 2025.

• For the quarter ending Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$184000.0; the trailing twelve-month figure through Dec 2025 stood at -$184000.0 (down 641.18% YoY), and the FY2025 full-year result was -$184000.0, down 641.18% from the prior year.
• Cash from Investing Activities for Q2 2025 stood at -$184000.0, down from -$11000.0 in the prior quarter.
• The five-year high for Cash from Investing Activities was $21.1 million in Q3 2023, with the low at -$230.0 million in Q2 2021.
• Average Cash from Investing Activities over 5 years is -$49.5 million, with a median of -$7.4 million recorded in 2022.
• Year-over-year, Cash from Investing Activities soared 262.8% in 2023 and slumped 110.89% in 2024.
• Tracing SNTI's Cash from Investing Activities over 5 years: stood at -$230.0 million in 2021, then surged by 78.64% to -$49.1 million in 2022, then soared by 100.21% to $101000.0 in 2023, then tumbled by 110.89% to -$11000.0 in 2024, then tumbled by 1572.73% to -$184000.0 in 2025.
• The last three Cash from Investing Activities figures came in at -$184000.0 (Q2 2025), -$11000.0 (Q4 2024), and $60000.0 (Q3 2024), per Business Quant data.

Peer Comparison